Jaffe posits that the drop in A1c and LDL levels was not only due to a readjustment in dosage or a switch in medication, but also possibly to better compliance to existing medication in patients with the most elevated levels.
FORBES: Largest Study Ever Links Electronic Health Records With Improved Patient Outcome